Methyl pyruvate → HCID 53751159, 화합물

HRID 328381

반응식

HRID 328381 반응식
Cl[C:2]1[CH:3]=[CH:4][C:5]2[N:11]=[C:10](NN)[CH2:9][N:8]=[C:7]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=3)[C:6]=2[CH:20]=1.C(OC)(=O)C(C)=O>CO>[C:14]1([C:7]2[C:6]3[CH:20]=[CH:2][CH:3]=[CH:4][C:5]=3[N:11]=[CH:10][CH2:9][N:8]=2)[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=1

참가 물질

4

실험 절차

A mixture of 5.7 g. (0.02 mole) of 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiazepine, 3 ml. (0.04 mole) of methyl pyruvate and 50 ml. of methanol is stirred, under nitrogen, for 17 hours at room temperature, by which time the solid has dissolved. Three ml. more methyl pyruvate is added and the solution is allowed to stand for 7 hours more. After filtration and evaporation in vacuo (50° C./0.5 mm.) a brown gum is obtained which is chromatographed on silica gel and eluted with 1% methanol in chloroform. Evaporation of the combined fractions containing the product (as indicated by thin layer chromatography) gives a gum which is crystallized from a mixture of chloroform and ether. A yield of 3.5 g. (67%) of 7-chloro-2-[[1-methoxycarbonyl)ethylidene]hydrazino]-5-phenyl-3H-1,4-benzodiazepine is obtained as nearly white crystals of melting point 156°-157° C. Melt solvate indicates the product contained 1.95% CHCl3 even after prolonged drying in vacuo.

후처리

  1. additionA mixture of 5.7 g
  2. dissolutionhas dissolved
  3. filtrationAfter filtration and evaporation in vacuo (50° C./0.5 mm.) a brown gum
  4. customis obtained which
  5. customis chromatographed on silica gel
  6. washeluted with 1% methanol in chloroform
  7. customEvaporation of the combined fractions
  8. additioncontaining the product (as indicated by thin layer chromatography)
  9. customgives a gum which
  10. customis crystallized from a mixture of chloroform and ether

출처 및 근거

ORD 기록
ord-e62459c7d01d41e2bcecb80f4214d39b
출처 데이터셋
uspto-grants-1977_04
특허 번호
US04017492

연결된 노트

불러오는 중…